Relevance of truncating titin mutations in dilated cardiomyopathy

Clinical Genetics

Volumn 90, Issue 1, 2016, Pages 49-54

  Akinrinade, O ^a   Alastalo, T P ^a,b   Koskenvuo, J W ^b,c  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b Blueprint Genetics   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

cardiomyopathy; genetic variation; titin

Indexed keywords

ARTICLE; CONGESTIVE CARDIOMYOPATHY; FRAMESHIFT MUTATION; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; NONSENSE MUTATION; PATHOGENICITY; PREVALENCE; PRIORITY JOURNAL; TITIN GENE;

EID: 84973594839     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12741     Document Type: Article

References (21)

1. Codd MB, Sugrue DD, Gersh BJ et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989: 80: 564–572.
2. John R, Rajasinghe HA, Chen JM et al. Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg 2001: 72: 440–449.
3. Towbin JA, Bowles NE. The failing heart. Nature 2002: 415: 227–233.
4. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 2005: 6: 185–216.
5. Dellefave L, McNally EM. The genetics of dilated cardiomyopathy. Curr Opin Cardiol 2010: 25: 198–204.
6. Kamisago M, Sharma SD, DePalma SR et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000: 343: 1688–1696.
7. Li D, Morales A, Gonzalez-Quintana J et al. Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci 2010: 3: 90–97.
8. Akinrinade O, Ollila L, Vattulainen S et al. Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy. Eur Heart J 2015: 36: 2327–2337.
9. Herman DS, Lam L, Taylor MR et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012: 366: 619–628.
10. Roberts AM, Ware JS, Herman DS et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med 2015: 7: 270ra276.
11. Haas J, Frese KS, Peil B et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015: 36: 1123–1135a.
12. Golbus JR, Puckelwartz MJ, Fahrenbach JP et al. Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet 2012: 5: 391–399.
13. Genomes Project C, Abecasis GR, Altshuler D et al. A map of human genome variation from population-scale sequencing. Nature 2010: 467: 1061–1073.
14. Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL: http://evs.gs.washington.edu/EVS/) [Accessed January 15, 2015].
15. Exome Aggregation Consortium (ExAC), Cambridge, MA (URL: http://exac.broadinstitute.org) [Accessed January 15, 2015].
16. Akinrinade O, Koskenvuo JW, Alastalo TP. Prevalence of titin truncating variants in general population. PLoS One 2015: 10: e0145284.
17. Gerull B, Gramlich M, Atherton J et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002: 30: 201–204.
18. Norton N, Li D, Rampersaud E et al. Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy. Circ Cardiovasc Genet 2013: 6: 144–153.
19. MacArthur DG, Balasubramanian S, Frankish A et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012: 335: 823–828.
20. Begay RL, Graw S, Sinagra G et al. Role of titin missense variants in dilated cardiomyopathy. J Am Heart Assoc 2015: 4: e002645.
21. Gramlich M, Michely B, Krohne C et al. Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease. J Mol Cell Cardiol 2009: 47: 352–358.